Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Chiappori

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 16, 2017
Somatic Mutations and Ancestry Markers in Hispanic Lung Cancer PatientsNicholas T Gimbrone, Bhaswati Sarcar, Edna R Gordian, et al.
International Journal of Radiation Oncology, Biology, Physics|January 19, 2023
Dose-Limiting Pulmonary Toxicity in a Phase 1/2 Study of Radiation and Chemotherapy with Ipilimumab Followed by Nivolumab for Patients With Stage 3 Unresectable Non-Small Cell Lung CancerCasey L Liveringhouse, Kujtim Latifi, Amalin G Asous, et al.
Nature Medicine|August 13, 2021
Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trialBenjamin C Creelan, Chao Wang, Jamie K Teer, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 16, 2017
Somatic Mutations and Ancestry Markers in Hispanic Lung Cancer PatientsNicholas T Gimbrone, Bhaswati Sarcar, Edna R Gordian, et al.
International Journal of Radiation Oncology, Biology, Physics|January 19, 2023
Dose-Limiting Pulmonary Toxicity in a Phase 1/2 Study of Radiation and Chemotherapy with Ipilimumab Followed by Nivolumab for Patients With Stage 3 Unresectable Non-Small Cell Lung CancerCasey L Liveringhouse, Kujtim Latifi, Amalin G Asous, et al.
Nature Medicine|August 13, 2021
Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trialBenjamin C Creelan, Chao Wang, Jamie K Teer, et al.
Pageof 6